Exosens among the strongest declines on the SBF 120: stock falls 3%
The Bordeaux-based optoelectronics company is moving against the grain of a rising Paris market. The decline occurs after a positive session and leaves the stock near its long-term moving averages.
A decline of more than 3% that brings the stock below its long-term moving averages
Exosens shares fall 3.11% to €59.20 in trading, while the SBF 120 gains 0.66%. This decline ranks it among the index's steepest drops, behind Aperam and Schneider Electric. The stock thus drops below its 50-day moving average at €59.98 (difference of 1.30%) and below its 200-day moving average at €59.81 (difference of 1.02%), while remaining above its 20-day moving average at €58.87€.
Over the week, the value declines 1.17%, which contrasts with a gain of 35.62% over one year. Today's movement erases part of the ground regained on Monday, when the stock had advanced 2% at the top of the index.
The €63.40 zone remains the resistance threshold and €54.15 the support level
In line with previous sessions, the price is evolving within a corridor bounded by a support at €54.15 and resistance at €63.40. The stock is positioned roughly midway between the two levels, having tested neither today. The RSI at 55 remains neutral and indicates neither overbought nor oversold conditions.
On the agenda, Exosens will publish its nine-month revenue on October 27. The group had raised its 2026 targets on September 17, with approximately 20% growth in revenue and approximately 25% growth in adjusted EBITDA, a revision that had propelled the stock to the top of the index that day.
